Washington University School of Medicine

Digital Commons@Becker
2020-Current year OA Pubs

Open Access Publications

7-1-2022

Association between the COVID-19 pandemic and insurancebased disparities in mortality after major surgery among US
adults
Laurent G Glance
University of Rochester

Andrew W Dick
RAND Health

Ernie Shippey
Vizient Center for Advanced Analytics

Patrick J McCormick
Memorial Sloan-Kettering Cancer Center

Richard Dutton
US Anesthesia Partners

See
next
page
additional
authors
Follow
this
andfor
additional
works
at: https://digitalcommons.wustl.edu/oa_4
Part of the Medicine and Health Sciences Commons

Recommended Citation
Glance, Laurent G; Dick, Andrew W; Shippey, Ernie; McCormick, Patrick J; Dutton, Richard; Stone, Patricia
W; Shang, Jingjing; Lustik, Stewart J; Lander, Heather L; Gosev, Igor; and Joynt Maddox, Karen E,
"Association between the COVID-19 pandemic and insurance-based disparities in mortality after major
surgery among US adults." JAMA Network Open. 5, 7. e2222360 (2022).
https://digitalcommons.wustl.edu/oa_4/562

This Open Access Publication is brought to you for free and open access by the Open Access Publications at
Digital Commons@Becker. It has been accepted for inclusion in 2020-Current year OA Pubs by an authorized
administrator of Digital Commons@Becker. For more information, please contact vanam@wustl.edu.

Authors
Laurent G Glance, Andrew W Dick, Ernie Shippey, Patrick J McCormick, Richard Dutton, Patricia W Stone,
Jingjing Shang, Stewart J Lustik, Heather L Lander, Igor Gosev, and Karen E Joynt Maddox

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/oa_4/562

Original Investigation | Diversity, Equity, and Inclusion

Association Between the COVID-19 Pandemic and Insurance-Based Disparities
in Mortality After Major Surgery Among US Adults
Laurent G. Glance, MD; Andrew W. Dick, PhD; Ernie Shippey, MS; Patrick J. McCormick, MD, MEng; Richard Dutton, MD, MBA; Patricia W. Stone, PhD, RN;
Jingjing Shang, PhD, RN; Stewart J. Lustik, MD, MBA; Heather L. Lander, MD; Igor Gosev, MD, PhD; Karen E. Joynt Maddox, MD, MPH

Abstract

Key Points

IMPORTANCE The COVID-19 pandemic caused significant disruptions in surgical care. Whether
these disruptions disproportionately impacted economically disadvantaged individuals is unknown.
OBJECTIVE To evaluate the association between the COVID-19 pandemic and mortality after major
surgery among patients with Medicaid insurance or without insurance compared with patients with
commercial insurance.

Question Was the COVID-19 pandemic
associated with greater changes in
mortality after major surgery among
patients with Medicaid insurance or
without insurance compared with
patients with commercial insurance?
Findings In this cross-sectional study of

DESIGN, SETTING, AND PARTICIPANTS This cross-sectional study used data from the Vizient

2 950 147 adults undergoing major

Clinical Database for patients who underwent major surgery at hospitals in the US between January

surgery, mortality rates among patients

1, 2018, and May 31, 2020.

with Medicaid insurance and patients
without insurance did not increase more

EXPOSURES The hospital proportion of patients with COVID-19 during the first wave of COVID-19

than the rate among patients with

cases between March 1 and May 31, 2020, stratified as low (ⱕ5.0%), medium (5.1%-10.0%), high

commercial insurance in hospitals with a

(10.1%-25.0%), and very high (>25.0%).

high COVID-19 burden compared with
hospitals with a low COVID-19 burden.

MAIN OUTCOMES AND MEASURES The main outcome was inpatient mortality. The association
between mortality after surgery and payer status as a function of the proportion of hospitalized
patients with COVID-19 was evaluated with a quasi-experimental triple-difference approach using
logistic regression.

Meaning These findings suggest that
the early phase of the pandemic was not
associated with increases in insurancebased disparities in mortality after
major surgery.

RESULTS Among 2 950 147 adults undergoing inpatient surgery (1 550 752 female [52.6%]) at 677
hospitals, the primary payer was Medicare (1 427 791 [48.4%]), followed by commercial insurance
(1 000 068 [33.9%]), Medicaid (321 600 [10.9%]), other payer (140 959 [4.8%]), and no insurance
(59 729 [2.0%]). Mortality rates increased more for patients undergoing surgery during the first
wave of the pandemic in hospitals with a high COVID-19 burden (adjusted odds ratio [AOR], 1.13; 95%

+ Supplemental content
Author affiliations and article information are
listed at the end of this article.

CI, 1.03-1.24; P = .01) and a very high COVID-19 burden (AOR, 1.38; 95% CI, 1.24-1.53; P < .001)
compared with patients in hospitals with a low COVID-19 burden. Overall, patients with Medicaid had
29% higher odds of death (AOR, 1.29; 95% CI, 1.22-1.36; P < .001) and patients without insurance
had 75% higher odds of death (AOR, 1.75; 95% CI, 1.55-1.98; P < .001) compared with patients with
commercial insurance. However, mortality rates for surgical patients with Medicaid insurance (AOR,
1.03; 95% CI, 0.82-1.30; P = .79) or without insurance (AOR, 0.85; 95% CI, 0.47-1.54; P = .60) did
not increase more than for patients with commercial insurance in hospitals with a high COVID-19
burden compared with hospitals with a low COVID-19 burden. These findings were similar in
hospitals with very high COVID-19 burdens.
CONCLUSIONS AND RELEVANCE In this cross-sectional study, the first wave of the COVID-19
pandemic was associated with a higher risk of mortality after surgery in hospitals with more than
25.0% of patients with COVID-19. However, the pandemic was not associated with greater increases
(continued)
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Abstract (continued)

in mortality among patients with no insurance or patients with Medicaid compared with patients
with commercial insurance in hospitals with a very high COVID-19 burden.
JAMA Network Open. 2022;5(7):e2222360. doi:10.1001/jamanetworkopen.2022.22360

Introduction
The COVID-19 pandemic led to hundreds of thousands of deaths and has created unprecedented disruptions in usual acute care across the US. During the initial COVID-19 surge in early 2020, many hospitals
experienced critical shortages of personal protective equipment and supplies and significant crowding.
As a result, nearly all US hospitals suspended elective and nonessential procedures, including major
operations, such as coronary artery bypass grafting and hip and knee replacements.1-3
These disruptions to usual surgical care may have disproportionately impacted disadvantaged
populations, including those covered by Medicaid or who are uninsured, groups previously
demonstrated to have worse surgical outcomes than their insured peers. Before the pandemic,
uninsured patients undergoing noncardiac and cardiac surgery had a greater than 50% higher risk of
mortality than did patients with private insurance.4,5 If the hospitals that typically provide care to
patients with Medicaid or uninsured patients were particularly likely to be overwhelmed with
COVID-19 or if the patients were particularly likely to have decrements in health during the pandemic,
the COVID-19 pandemic may have been associated with a widening of these already stark gaps in
surgical outcomes. Furthermore, individuals from racial and ethnic minority groups have been
disproportionately affected by COVID-19, accounting for 36% of COVID-19–related deaths and 70%
of non–COVID-19–related excess deaths.6 Because Black and Hispanic individuals are
disproportionately more likely to lack insurance coverage—while 9% of non-Hispanic White
individuals lack health insurance, 31% of Hispanic and 15% of non-Hispanic Black individuals are
uninsured7—any decrements to uninsured populations may worsen gaps in racial and ethnic equity
and may have contributed to excess non-COVID mortality.
Our goal in this study was to examine whether the pandemic was associated with a widening of
the gap in health outcomes between insured and uninsured individuals undergoing major surgery.
COVID-19 created a natural experiment to examine whether hospitals under stress deliver lowerquality care and whether the lower-quality care disproportionately affects uninsured individuals and
individuals with Medicaid. We used the wide differences in COVID-19 burden across hospitals (as
measured by the proportion of hospitalized patients with COVID-19) to examine the association
between the pandemic and surgical outcomes in patients with Medicaid or without insurance
compared with patients with commercial insurance.

Methods
The University of Rochester Research Study Review Board reviewed this study and determined that
it met federal and university criteria for exemption because it consisted of secondary research on
existing data. Therefore, informed consent was not required. The Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) reporting guideline was used to guide the
reporting of this study.8

Data Source
This cross-sectional study was performed using data on patients hospitalized for major surgery from
the Vizient Clinical Database, formerly known as the University HealthSystem Consortium. Vizient
includes more than 90% of academic medical centers in the US and their affiliated hospitals.9 These
data have been used in multiple prior studies.10-13 The database contains information on patient
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demographic characteristics (age, sex, and self-reported race and ethnicity), payer status
(commercial insurance, Medicare, Medicaid, uninsured, or other payer), admission status (elective,
urgent, or emergency), International Statistical Classification of Diseases and Related Health
Problems, Tenth Revision diagnostic and procedure codes, encrypted hospital identifiers, all-cause
inpatient mortality, and hospital characteristics.

Study Population
Adult inpatient hospitalizations between January 1, 2018, and May 31, 2020, were included. We
grouped operations using the coding algorithm from the Centers for Disease Control and Prevention
National Healthcare Safety Network.14 We included the following major operations in the analysis:
abdominal aortic aneurysm repair; limb amputations; appendix surgery; bile duct, liver, or pancreatic
surgery; coronary artery bypass graft surgery; cardiac surgery (eg, aortic valve replacement); carotid
endarterectomy; cholecystectomy; colon surgery; craniotomy; spinal fusion; fracture surgery; gastric
surgery; knee arthroplasty; hip arthroplasty; laminectomy; peripheral vascular bypass surgery;
small-bowel surgery; thoracic surgery; and exploratory laparotomy. We excluded patients with
missing data on admission status, age, sex, or race and ethnicity; patients in hospitals with missing
information on the proportion of patients who tested positive for COVID-19; and patients from
hospitals that were not included in the database in both the baseline period and the first wave of the
pandemic (eFigure 1 in the Supplement).

Statistical Analysis
Our goal was to examine the differential association of the pandemic with outcomes among patients
undergoing major surgery as a function of the primary payer status. The outcome of interest was
inpatient all-cause mortality. We hypothesized that the pandemic would be associated with increases
in surgical mortality and that these increases would be greater for uninsured patients or patients with
Medicaid compared with patients with commercial insurance.
We used univariate logistic regression to describe differences in key characteristics of patients
by payer status. We analyzed changes in inpatient all-cause mortality before the pandemic
(prepandemic period [January 1, 2018, to February 29, 2020]) and during the first wave of the
pandemic (surge [March 1 to May 31, 2020]) as a function of the hospital COVID-19 burden. The
exposure was the hospital proportion of patients with COVID-19 during the first wave of COVID-19
cases between March 1 and May 31, 2020, stratified as low (ⱕ5.0%), medium (5.1%-10.0%), high
(10.1%-25.0%), and very high (>25.0%) (eFigure 2 in the Supplement). We quantified the hospital
COVID-19 burden as the maximum proportion of patients in a hospital who tested positive for
COVID-19 during the surge period. We estimated a multivariable logistic regression model (model 1):
f[E(Yiht)] = β0 + β1Surge + β2COVIDh + β3Surge × COVIDh + β4Xiht + β5Siht
where f is the logit function, Yiht is the outcome (live or die) for patient i during the surge period (0 for
baseline and 1 for first wave of the pandemic) who underwent surgery in hospital h with COVID-19
burden COVIDh. Xiht is a vector of patient characteristics (age, sex, admission urgency, Elixhauser
comorbidities, and COVID-19 test result), and Siht is a vector of surgical procedures. We characterized
the association between mortality and hospital COVID-19 burden using β3.
We then analyzed changes in the association between inpatient all-cause mortality and payer
status before the pandemic (prepandemic period [January 1, 2018, to February 29, 2020]) and
during the first wave of the pandemic (surge [March 1 to May 31, 2020]) for all hospitals regardless of
the hospital COVID-19 burden. We estimated a multivariable logistic regression model (model 2):
f[E(Yijt)] = β0 + β1Surge + β2Payerj + β3Surge × Payerj + β4Xijt + β5Sijt
where the payer status is specified by Payerj (commercial insurance, Medicare, Medicaid, other
payers, or no insurance). We characterized the relative change in mortality between the baseline
period and the surge period as a function of payer status using β3.
JAMA Network Open. 2022;5(7):e2222360. doi:10.1001/jamanetworkopen.2022.22360 (Reprinted)
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Finally, we examined whether the association between mortality and payer status during the
pandemic was a function of the hospital COVID-19 burden using a quasi-experimental tripledifference (DDD) approach. We assumed that patients in hospitals with a very low COVID-19 burden
belonged to the untreated group, whereas patients in hospitals with higher COVID-19 burdens
belonged to the treatment group. We estimated a multivariable logistic regression model (model 3):
f[E(Yijht)] = β0 + β1Surge + β2Payerj + β3COVIDh + β4Surge × Payerj
+ β5Surge × COVIDh + β6Payerj × COVIDh + β7Surge × COVIDh × Payerj + β8Xijht + β9Sijht
where COVIDh is the hospital COVID-19 burden, and the other variables are the same as those in
models 1 and 2. We characterized the relative change in mortality between the prepandemic period
and the surge period for patients with no insurance or with Medicaid vs patients with commercial
insurance as a function of the hospital COVID-19 burden using the coefficient for the 3-way
interaction term β7.
We also conducted several sensitivity analyses. First, we reestimated model 1 separately for
patients undergoing (1) elective surgery, (2) urgent surgery, and (3) emergency surgery. Second, we
reestimated model 2 separately for each stratum of hospital COVID-19 burden as a sensitivity analysis
for the DDD model.
In addition to the sensitivity analyses, we performed 2 post hoc analyses in response to
reviewer comments after peer review. We used negative binomial regression to estimate changes in
surgical case volumes as a function of the hospital COVID-19 burden during the surge for patients
undergoing urgent and emergency operations by specifying the period and the hospital COVID-19
burden as main effects and an interaction between period and the hospital COVID-19 burden. We
used the log of the number of months in each period as the offset in the negative binomial
regression model.
We used logistic regression analysis to estimate whether the proportion of patients with
Medicaid or no insurance increased more in hospitals with a high COVID-19 burden compared with
hospitals with a low COVID-19 burden during the surge period. We specified the following model
(model 4):
f[E(Yiht)] = β0 + β1Surget + β2Urgencyiht + β3COVIDh + β4Surget × Urgencyiht
+ β5Surge × COVIDh + β6Urgencyiht × COVIDh + β7Surget × Urgencyiht × COVIDh
where f is the logit function, Yiht is whether a patient had Medicaid or no insurance (coded as 1) and
all other payers (coded as 0), Surget is the period (baseline or surge), Urgencyiht is the surgical
urgency of the procedure for patient i in period t in hospital h, and COVIDh is the hospital COVID-19
burden. We characterized the relative change in the proportion of patients with Medicaid or no
insurance in hospitals who underwent urgent or emergency surgery in hospitals with a high COVID-19
burden compared with hospitals with a low COVID-19 burden during the surge period using β7.
Data management and statistical analyses were performed using Stata SE/MP software, version
17.0 (StataCorp LLC). We used cluster robust variance estimators in the adjusted analyses to account
for the clustering of patients within hospitals. All statistical tests were 2-tailed, and P < .05 was
considered significant.

Results
We identified 3 038 518 adult inpatient hospitalizations for major surgery at 713 hospitals during the
study period. After excluding patients with missing data on admission status (n = 2611), age (n = 5),
sex (n = 210), or race and ethnicity (n = 61 344); from hospitals with missing information on the
proportion of patients who tested positive for COVID-19 (n = 24 055); and from hospitals that were
not included in the database in both the baseline period and the first wave of the pandemic (n = 146),
the final analytic data set consisted of 2 950 147 patients in 677 hospitals. Among these 2 950 147
patients (1 550 752 female [52.6%]), the primary payer was Medicare (1 427 791 [48.4%]), followed
JAMA Network Open. 2022;5(7):e2222360. doi:10.1001/jamanetworkopen.2022.22360 (Reprinted)
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by commercial insurance (1 000 068 [33.9%]), Medicaid (321 600 [10.9%]), other payer (140 959
[4.8%]), and no insurance (59 729 [2.0%]) (Table 1 and eTable 1 in the Supplement). A total of
202 911 operations (6.9%) occurred during the first wave of the pandemic. A total of 1 414 204
operations (47.9%) were performed in hospitals with a peak COVID-19 burden of 5.0% or less,
whereas 607 068 (20.6%) were performed in hospitals with a peak COVID-19 burden of 10.1% to
25.0% and 415 080 (14.1%) in hospitals with a peak COVID-19 burden greater than 25.0%. A total of
1 777 879 operations (60.3%) were elective, whereas 278 239 (9.4%) were urgent and 894 029
(30.3%) were emergency. A total 59 472 patients (2.0%) self-identified as Asian, 381 772 (12.9%) as
Black, 2 299 899 (78.0%) as White, and 209 004 (7.1%) as other race and ethnicity.
Compared with patients with commercial insurance, Medicare, or other payers, patients with
Medicaid or no insurance were more likely to undergo urgent (odds ratio [OR], 1.74; 95% CI, 1.72-1.77;
P < .001) or emergency (OR, 2.42; 95% CI, 2.40-2.44; P < .001) surgery; to be Asian (OR, 2.11; 95%
CI, 2.07-2.16; P < .001), Black (OR, 2.96; 95% CI, 2.94-2.99; P < .001), or other race and ethnicity (OR,
4.09; 95% CI, 4.05-4.13; P < .001); to test positive for COVID-19 (OR, 2.20; 95% CI, 1.99-2.43;
P < .001); and to have comorbidities, including paralysis, liver disease, HIV infection, alcohol abuse,

Table 1. Patient Characteristics by Payer Status
Patients, No. (%)
Total
(N = 2 950 147)

Commercial insurance
(n = 1 000 068)

Medicare
(n = 1 427 791)

Medicaid
(n = 321 600)

Uninsured
(n = 59 729)

Other payer
(n = 140 959)

≤5.0

1 414 204 (47.9)

468 163 (46.8)

708 879 (49.7)

141 802 (44.1)

32 403 (54.3)

62 957 (44.7)

5.1-10.0

513 795 (17.4)

161 309 (16.1)

243 337 (17)

57 993 (18)

16 520 (27.7)

34 636 (24.6)

10.1-25.0

607 068 (20.6)

227 763 (22.8)

286 627 (20.1)

63 070 (19.6)

6199 (10.4)

23 409 (16.6)

>25.0

415 080 (14.1)

142 833 (14.3)

188 948 (13.2)

58 735 (18.3)

4607 (7.7)

19 957 (14.2)

Baseline

2 747 236 (93.1)

935 033 (93.5)

1 329 865 (93.1)

296 969 (92.3)

54 416 (91.1)

130 953 (92.9)

Surge

202 911 (6.9)

65 035 (6.5)

97 926 (6.9)

24 631 (7.7)

5313 (8.9)

10 006 (7.1)

51 469 (36.5)

Characteristic
Hospitalized with
COVID-19, %

Period

Admission status
Emergency

894 029 (30.3)

232 370 (23.2)

434 120 (30.4)

137 625 (42.8)

38 445 (64.4)

Urgent

278 239 (9.4)

82 336 (8.2)

141 150 (9.9)

34 280 (10.7)

7538 (12.6)

12 935 (9.2)

Elective

1 777 879 (60.3)

685 362 (68.5)

852 521 (59.7)

149 695 (46.6)

13 746 (23)

76 555 (54.3)

Female

1 550 752 (52.6)

521 922 (52.2)

776 419 (54.4)

174 933 (54.4)

26 221 (43.9)

51 257 (36.4)

Male

1 399 395 (47.4)

478 146 (47.8)

651 372 (45.6)

146 667 (45.6)

33 508 (56.1)

89 702 (63.6)

18-30

149 731 (5.1)

74 078 (7.4)

4782 (0.3)

47 672 (14.8)

10 326 (17.3)

12 873 (9.1)

31-50

521 567 (17.7)

282 782 (28.3)

52 258 (3.7)

121 455 (37.8)

24 329 (40.7)

40 743 (28.9)

51-64

918 197 (31.1)

531 128 (53.1)

170 981 (12)

137 770 (42.8)

21 532 (36.1)

56 786 (40.3)

65-74

792 220 (26.9)

93 631 (9.4)

664 564 (46.5)

9716 (3)

2321 (3.9)

21 988 (15.6)

75-79

273 891 (9.3)

11 351 (1.1)

254 711 (17.8)

2537 (0.8)

612 (1)

4680 (3.3)

80-84

162 233 (5.5)

4426 (0.4)

153 818 (10.8)

1475 (0.5)

349 (0.6)

2165 (1.5)

85-89

86 588 (2.9)

1879 (0.2)

82 723 (5.8)

664 (0.2)

143 (0.2)

1179 (0.8)

≥90

45 720 (1.6)

793 (0.1)

43 954 (3.1)

311 (0.1)

117 (0.2)

545 (0.4)

Asian

59 472 (2)

23 072 (2.3)

22 852 (1.6)

9587 (3)

1160 (1.9)

2801 (2)

Black

381 772 (12.9)

110 739 (11.1)

156 203 (10.9)

78 347 (24.4)

11 926 (20)

24 557 (17.4)

Sex

Age group, y

Race

White

2 299 899 (78)

802 875 (80.3)

1 183 060 (82.9)

182 522 (56.8)

35 171 (58.9)

96 271 (68.3)

Othera

209 004 (7.1)

63 382 (6.3)

65 676 (4.6)

51 144 (15.9)

11 472 (19.2)

17 330 (12.3)

1969 (0.97)

429 (0.66)

936 (0.96)

440 (1.79)

40 (0.75)

124 (1.24)

Tested positive for
COVID-19 during surgeb
a

All individuals of races other than White, Black, and Asian were grouped in the other
category because the original data were categorized in this manner.

b

The surge period was defined as the period from March 1 to May 31, 2020.
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drug abuse, and psychosis (eTable 1 in the Supplement). A total of 113 hospitals (16.7%) had 500 or
more beds, and 307 (45.3%) had fewer than 100 beds. A total of 346 hospitals (51.1%) had a peak
inpatient COVID-19 census of 5.0% or less, and 84 (12.4%) had a peak inpatient COVID-19 census
greater than 25.0% (Table 2).
Mortality rates increased more among patients undergoing surgery during the first wave of the
pandemic in hospitals with high (adjusted OR [AOR], 1.13; 95% CI, 1.03-1.24; P = .01) and very high
(AOR, 1.38; 95% CI, 1.24-1.53; P < .001) COVID-19 burdens compared with patients in hospitals with a
low COVID-19 burden (Figure 1 and eTable 2 in the Supplement). Mortality rates increased more for
urgent (AOR, 1.59; 95% CI, 1.27-2.00; P < .001) and emergency surgery (AOR, 1.40; 95% CI, 1.24-1.59;
P < .001) than for elective surgery (AOR, 0.94; 95%, 0.66-1.33; P = .72) in hospitals with very high
COVID-19 burdens compared with hospitals with a low COVID-19 burden (Figure 1 and eTable 2 in the
Supplement).
Patients with Medicaid insurance had 29% higher odds of death (AOR, 1.29; 95% CI, 1.22-1.36;
P < .001) and patients without insurance had 75% higher odds of death (AOR, 1.75; 95% CI, 1.55-1.98;
P < .001) compared with patients with commercial insurance (eTable 3 in the Supplement). Mortality
rates did not increase more during the first wave of the pandemic among patients with Medicaid
(AOR, 1.08; 95% CI, 0.96-1.20; P = .20) or without insurance (AOR, 1.09; 95% CI, 0.90-1.32; P = .38)
compared with patients with commercial insurance (Figure 2 and eTable 3 in the Supplement).
On the basis of the DDD analysis in which we examined the differential association by payer of
the first wave of the pandemic with outcomes among patients undergoing surgery in hospitals with
high vs low COVID-19 burdens, there was no evidence that patients with Medicaid insurance or no
insurance were more adversely affected by undergoing surgery in hospitals with a high COVID-19
burden compared with patients with commercial insurance (joint test for triple interaction term:
P = .94). The results of the baseline model (model 2) stratified by hospital COVID-19 burden are given

Table 2. Hospital Characteristics
Characteristic

Hospitals, No. (%) (N = 677)

Census zone
Midwest
East North Central

141 (20.8)

West North Central

81 (12)

Northeast
Middle Atlantic

102 (15.1)

New England

47 (6.9)

South
East South Central

15 (2.2)

South Atlantic

115 (17)

West South Central

59 (8.7)

West
Mountain

59 (8.7)

Pacific

52 (7.7)

Missing data

6 (0.9)

Total beds
<100

307 (45.3)

100-249

139 (20.5)

250-499

118 (17.4)

≥500

113 (16.7)

COVID-19 burden during surge, %a
≤5.0

346 (51.1)

5.1-10.0

127 (18.8)

10.1-25.0

120 (17.7)

>25.0

84 (12.4)
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in Figure 2 and eTable 3 in the Supplement, and the results of the DDD model are given in eTable 4 in
the Supplement. The mortality rate among patients with Medicaid (AOR, 1.03; 95% CI, 0.82-1.30;
P = .79) or without insurance (AOR, 0.85; 95% CI, 0.47-1.54; P = .60) did not increase more than that
among patients with commercial insurance in hospitals with a high COVID-19 burden compared with
hospitals with a low COVID-19 burden (Figure 2 and eTable 3 in the Supplement). These findings were
similar in hospitals with very high COVID-19 burdens. We tested the parallel trend assumption in the
baseline period by including a continuous variable for month and interacting it with payer and with
the hospital COVID-10 burden and did not find any evidence of a violation of the parallel trend
assumption.
In our first post hoc analysis, we found that compared with the baseline period, emergency
surgery case volumes were more reduced in hospitals with high (incident rate ratio, 0.88; 95% CI,
0.86-0.90; P < .001) and very high (incident rate ratio, 0.82; 95% CI, 0.80-0.84; P < .001) COVID-19
burdens compared with hospitals with very low COVID-19 burdens. We found similar results for
urgent operations in hospitals with high (OR, 0.92; 95% CI, 0.88-0.95; P < .001) and very high (OR,
0.66; 95% CI, 0.63-0.70; P < .001) COVID-19 burdens (eFigure 3 in the Supplement).
In our second post hoc analysis, we found that the proportion of patients with Medicaid or
without insurance undergoing emergency surgery increased more in hospitals with a very high
COVID-19 burden (OR, 1.13; 95% CI, 1.01-1.28; P = .04) but not in hospitals with a high COVID-19
burden (OR, 1.11; 95% CI, 0.99-1.24; P = .07) compared with hospitals with a low COVID-19 burden.
We found no evidence of increases in the proportion of patients with Medicaid or without insurance
undergoing urgent surgery during the surge period (eFigure 4 in the Supplement).

Discussion
In this cross-sectional study of 2 950 147 patients undergoing major inpatient surgical procedures at
677 US hospitals, we found that the odds of mortality in hospitals with a very high COVID-19 burden
increased 38% more during the first wave of the pandemic than in hospitals with a low COVID-19

Figure 1. Changes in Mortality Between the Baseline and Surge Periods as a Function of Hospital COVID-19
Burden for All Surgeries and Then Stratified by Surgical Urgency
Baseline Surge
adjusted adjusted Unadjusted OR
mortality mortality (95% CI)

Adjusted OR
(95% CI)
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1.06 (0.83-1.37) 1.05 (0.80-1.37)

.74

>25.0
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<.001
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.06
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burden. These odds were greater among patients requiring urgent and emergency surgery than
among those requiring elective surgery. Patients with Medicaid or no insurance had 29% and 75%
higher odds of mortality, respectively, than patients with commercial insurance. However, patients
who lacked insurance or had Medicaid did not experience greater changes in mortality during the first
wave of the pandemic compared with patients with commercial insurance. These findings suggest
that the pandemic did not exacerbate the mortality gap between patients with no insurance or
Medicaid and patients with commercial insurance.
The effect of COVID-19 on the US health care system is unprecedented. Surges in hospital
admissions have led to shortages of hospital beds, critical care unit beds, ventilators, personal
protective equipment, and staff availability.15 Overcrowding is associated with increased COVID-19
mortality and possibly with excess non–COVID-19 deaths.15-17 In response to the first wave of the
pandemic, the Centers for Medicare & Medicaid Services recommended that all elective and
nonessential operations be delayed to free health care resources and staff to care for patients with
COVID-19.18 Our study found that despite the substantial reduction in surgical case volumes,19
increases in overall hospital COVID-19 caseloads were associated with worse outcomes in surgical
patients, especially in those undergoing urgent and emergency surgery. Whether this finding was
associated with patients presenting later in their acute illness because of heightened fear of

Figure 2. Changes in Mortality Between the Baseline and Surge Periods as a Function of Payer Status for All
Hospitals and Then Stratified by Hospital COVID-19 Burden
Baseline Surge
adjusted adjusted Unadjusted OR
mortality mortality (95% CI)

Adjusted OR
(95% CI)
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contracting COVID-19 at their local hospital or whether it suggests a higher level of care disruption in
hospitals with a higher COVID-19 burden is unclear, and it is likely that both factors contributed to
some degree. However, this increase in mortality did not disproportionately affect disadvantaged
patients with no insurance or Medicaid. This finding is particularly important in light of the
disproportionate effects of COVID-19 on individuals from racial and ethnic minority groups, many of
whom lacked insurance or had Medicaid instead of commercial insurance.20
Our study supports extensive and longstanding evidence that uninsured individuals or
individuals with Medicaid have worse health outcomes than patients with commercial
insurance.4,5,21-24 However, it is difficult to disentangle the extent to which these worse outcomes
are associated with lower-quality medical care or whether the lack of insurance or Medicaid serves as
a proxy for worse health status. The pandemic can serve as a natural experiment to help understand
the association of the health care system with this disparity in outcomes. If the health care system
contributed to disparities in surgical outcomes through discrimination against uninsured or Medicaidinsured patients, one would expect that the increases in mortality during the pandemic would be
worse in these groups because hospitals under stress would allocate their limited resources to more
advantaged individuals. Using quasi-experimental methods, our study suggests that although
inpatient surgical outcomes worsened during the pandemic, patients with or without insurance were
affected equally. Because our study was limited to inpatient mortality, it did not examine the
differential association of the pandemic with the health of individuals with low income before they
were admitted for surgery. Our study also did not examine the association of the pandemic with
postdischarge outcomes among patients with low income. Nonetheless, during the acute care
hospitalization, insurance-based disparities did not worsen. However, given the marked inequities in
surgical outcomes that we and others have reported,25 these findings should not cause health care
policy makers or frontline clinicians to be complacent about the health care challenges that
individuals with low income experience before and after they leave the hospital. Moreover, the
health care challenges experienced by individuals with low income may continue to increase because
of ongoing job losses and continued exposure to COVID-19,26 which may further exacerbate
economic disparities and disrupt insurance coverage. It will be important to track the long-term
effects of delays and disruptions to surgical care among disadvantaged groups even after the COVID
pandemic has waned.

Limitations
This study has several important limitations. First, we used inpatient mortality instead of 30-day
mortality. It is possible that hospitals discharged patients sooner during the pandemic to increase bed
availability for patients with COVID-19 and that patients without insurance or with Medicaid were
more likely to be discharged sooner compared with patients with commercial insurance and thus
were less likely to die in the hospital. Therefore, increases in inpatient mortality among patients
without insurance or with Medicaid during the pandemic could have been masked by earlier hospital
discharges. Second, some patients lost employment-based insurance during the pandemic and may
have become uninsured or obtained Medicaid coverage. As a result, the pool of uninsured individuals
or individuals with Medicaid may have included healthier patients who lost their employersponsored insurance during the pandemic. However, the rate of decline in employer-sponsored
insurance during the pandemic (0.2 percentage points each week) was likely too small to bias our
findings.27 Third, we did not examine complication outcomes because of the systematic
underreporting of postoperative complications in administrative data.28,29 Fourth, our findings may
not be generalizable because they are based on a sample of US hospitals. However, our study is the
largest multicenter study to date to examine the association of COVID-19 with surgical outcomes and
includes a broadly representative set of hospitals. Fifth, our findings in this retrospective study
should be interpreted cautiously because observational studies are subject to unmeasured
confounding, especially when based on administrative data. In particular, mortality rates in hospitals
with the highest burden of patients with COVID-19 may have increased compared with hospitals with

JAMA Network Open. 2022;5(7):e2222360. doi:10.1001/jamanetworkopen.2022.22360 (Reprinted)

Downloaded From: https://jamanetwork.com/ by a Washington University - St Louis User on 11/16/2022

July 18, 2022

9/12

JAMA Network Open | Diversity, Equity, and Inclusion

COVID-19 Pandemic and Insurance-Based Disparities in Mortality After Major Surgery

the lowest burden of patients with COVID-19 in part because hospitals with high COVID-19 burden
limited admissions to patients who were sicker compared with hospitals with low COVID-19 burden.
In particular, we found that hospitals with the highest COVID-19 burden experienced greater
reductions in urgent and emergency operations compared with hospitals with the lowest COVID-19
burden. We also found that the proportion of patients with Medicaid or without insurance
undergoing emergency surgery increased slightly in hospitals with very high COVID-19 burdens
during the surge compared with hospitals with a low COVID-19 burden. These findings suggest that
hospitals under the greatest stress may have preferentially operated on the sickest patients, which
could partly account for the higher mortality rates in hospitals with the highest COVID-19 burdens.

Conclusions
In this cross-sectional study, the first wave of the COVID-19 pandemic was associated with a higher
risk of mortality after surgery in hospitals with a very high burden of COVID-19–positive patients.
Although patients with Medicaid or without health insurance were more likely to die after surgery
compared with patients with commercial insurance, the pandemic was not associated with greater
increases in mortality among these patients than among patients with commercial insurance.
Improving outcomes in economically disadvantaged populations may require a greater emphasis on
improving the general health of patients from these populations before surgery to narrow the
mortality gap after surgery between economically disadvantaged patients and patients with
commercial insurance.
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